Refractory Chronic Lymphocytic Leukemia
Showing NaN - NaN of 19
Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +15 more
- Anti-CD19/CD20/CD22 CAR T-Cells
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 4, 2022
Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt
Active, not recruiting
- Prolymphocytic Leukemia
- +4 more
- Selinexor
- +3 more
-
Columbus, Ohio
- +1 more
Apr 29, 2022
Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial
Active, not recruiting
- Contiguous Stage II Small Lymphocytic Lymphoma
- +11 more
- MOR00208
- +2 more
-
Columbus, OhioThe Ohio State University Comprehensive Cancer Center
Feb 24, 2022
Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus (drug, biological, other)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Refractory Chronic Lymphocytic Leukemia
- Bcl-2 Inhibitor GDC-0199
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 29, 2021
Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,
Completed
- Chronic Lymphocytic Leukemia
- +3 more
- Dinaciclib
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 15, 2018
Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia in Remission
- +41 more
- Laboratory Biomarker Analysis
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 22, 2017
Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in United
Completed
- Chronic Lymphocytic Leukemia
- +2 more
- Akt Inhibitor MK2206
- +3 more
-
Scottsdale, Arizona
- +43 more
Aug 17, 2017
B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +3 more
-
Columbus, OhioOhio State University Medical Center
Jun 2, 2017
B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +2 more
-
Columbus, OhioOhio State University Medical Center
Aug 31, 2016
B-cell Chronic Lymphocytic Leukemia, Hematopoietic/Lymphoid Cancer, Prolymphocytic Leukemia Trial in Columbus (carfilzomib,
Completed
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- carfilzomib
- +4 more
-
Columbus, OhioOhio State University Medical Center
May 6, 2016
Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,
Terminated
- Chronic Lymphocytic Leukemia
- +11 more
- Alvocidib Hydrochloride
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 10, 2015
B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +3 more
- alvespimycin hydrochloride
- +3 more
-
Columbus, OhioOhio State University Medical Center
Nov 3, 2015
Anemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia Trial in Columbus (Alvocidib Hydrochloride, Lenalidomide,
Completed
- Anemia
- +5 more
- Alvocidib Hydrochloride
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 1, 2015
Noncontiguous Stage II Small Lymphocytic Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia
Completed
- Noncontiguous Stage II Small Lymphocytic Lymphoma
- +4 more
- apolizumab
- +2 more
-
La Jolla, California
- +1 more
Jul 15, 2013
B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +2 more
- tanespimycin
- rituximab
-
Columbus, OhioOhio State University Medical Center
Jun 3, 2013
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Columbus
Terminated
- Adult Acute Basophilic Leukemia
- +34 more
-
Columbus, OhioOhio State University Medical Center
Jun 3, 2013
MALT, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma Trial in Columbus (apolizumab,
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +13 more
- apolizumab
- +2 more
-
Columbus, OhioOhio State University Medical Center
Jun 3, 2013
B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular
Completed
- B-cell Chronic Lymphocytic Leukemia
- +42 more
- alvocidib
- +3 more
-
Columbus, OhioOhio State University Medical Center
Jun 3, 2013